id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S18385 R77535 |
Kananen - Quetiapine, 2023 | Low 5-min Apgar score (≤ 7) | during pregnancy (anytime or not specified) | retrospective cohort | unexposed (general population or NOS) | Adjustment: Yes | 1.05 [0.60;1.82] | 15/152 1,609/35,133 | 1,624 | 152 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3851 R8202 |
Ellfolk (Control exposed to FGA), 2019 | Apgar 5 min 0–6 | during pregnancy (anytime or not specified) | population based cohort retrospective | exposed to other treatment, sick excluded | Adjustment: Yes |
0.81 [0.55;1.20] excluded (control group) |
212/- 38/- | 250 | - |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3818 R8138 |
Ellfolk (Control unexposed), 2019 | Apgar 5 min 0–6 | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed (general population or NOS) | Adjustment: Yes | 1.82 [1.38;2.39] | 212/4,204 399/21,069 | 611 | 4,204 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S2378 R2917 |
Frayne (Control exposed to antidepressants), 2018 | Apgar < 8 at 5 min | during pregnancy (anytime or not specified) | retrospective cohort | exposed to other treatment, sick excluded | Adjustment: No |
0.52 [0.15;1.82] C excluded (control group) |
5/75 6/50 | 11 | 75 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S2285 R2916 |
Frayne (Control unexposed, sick), 2018 | Apgar < 8 at 5 min | during pregnancy (anytime or not specified) | retrospective cohort | unexposed, sick | Adjustment: No | 0.96 [0.25;3.76] C | 5/75 4/58 | 9 | 75 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 3 studies | 1.43 [0.92;2.21] | 2,244 | 4,431 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Control unexposed; 2: Control unexposed, sick;
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded 2378, 3851